Aim & Scope
Nature Biomedical Engineering aspires to become the most prominent publishing venue in biomedical engineering by bringing together the most important advances in the discipline, enhancing their visibility by means of opinion and news articles, and providing overviews of the state of the art in each field through topic-, disease- or technology-focused review articles. The journal's editorial team strives for excellence in content selection, commissioning and editing, in author and reviewer service, and in engagement with the biomedical engineering community. In particular, Nature Biomedical Engineering aims to cover the full spectrum of research from the interdisciplinary discipline of biomedical engineering, inspire biomedical engineers to help solve outstanding health challenges, and effectively disseminate the successes of the discipline to the wider scientific community; uphold the standards of content quality and author service expected of the Nature-branded family of journals; engage with the broad biomedical engineering community, through regular editorial presence at key conferences, visits to laboratories and hospitals, and participation in social media. Research in biomedical engineering involves both discovery and invention. Clinical advances provide input for further improvements in methodology and for generating hypotheses to be tested in the laboratory; and conversely, the results of fundamental advances in biology, medicine, materials and physicochemical and engineering processes can lead to the development of therapy and technology that may reach the clinic. Indeed, major inventions of biomedical engineering — such as artificial joints, magnetic resonance imaging, heart pacemakers, heart–lung machines and angioplasties — are built on findings stemming from basic research and have enabled further discoveries. By publishing content that traverses field boundaries, Nature Biomedical Engineering helps to build bridges between bench researchers, clinicians and medical engineers. Straddling the life sciences, the physical sciences and engineering, Nature Biomedical Engineering covers materials, therapies, devices, technology, systems, methods and processes that facilitate the understanding of human disease, or its prevention, diagnosis, treatment, alleviation or monitoring. The journal disseminates biological, medical and engineering advances — of fundamental, mechanistic, methodological, technological, therapeutic, translational or clinical nature — that can directly lead to or inspire improvements in human health or healthcare. The emphasis is on advances that draw on both the biomedical sciences and the physical sciences, engineering, mathematics or informatics. The scope hence excludes advances that improve the understanding of human biology or disease but whose relevance for health or healthcare is judged to be insufficient, as well as advances that do not make use of principles or tools from the physical sciences or engineering. [1]
Series / Collection
0028-0836 ( Print )
1476-4687 ( Online )
Nature Research
,
Springer
Nature Biomedical Engineering
2157-846X ( Online )
Nature Research
,
Springer
1087-0156 ( Print )
1546-1696 ( Online )
Nature Research
,
Springer
2731-0590 ( Online )
Nature Research
,
Springer
1465-7392 ( Print )
1476-4679 ( Online )
Nature Research
,
Springer
2024
F Carrillo-Perez , M Pizurica , Y Zheng , ... , O Gevaert
Nature Biomedical Engineering , 2024
Spatial multi-omics at subcellular resolution via high-throughput in situ pairwise sequencing
X Wu , W Xu , L Deng , ... , G Cao
Nature Biomedical Engineering , 2024
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers
D Yin , Y Zhong , S Ling , ... , Y Cai
Nature Biomedical Engineering , 2024
Strategies for the development of metalloimmunotherapies
X Sun , X Zhou , X Shi , ... , JJ Moon
Nature Biomedical Engineering , 2024
Deep-learning-enabled antibiotic discovery through molecular de-extinction
F Wan , MDT Torres , J Peng , C de la Fuente-Nunez
Nature Biomedical Engineering , 2024
Histopathological biomarkers for predicting the tumour accumulation of nanomedicines
JN May , JI Moss , F Mueller , ... , T Lammers
Nature Biomedical Engineering , 2024
Editorial Retractions, Expressions of Concern and External Notices
JJ Credle , J Gunn , P Sangkhapreecha , ... , H Benjamin Larman
Nature Biomedical Engineering2022 - VOLUME 6, ISSUE 8 pp 992-1003.
14 59
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria.
Y Chen , S Lin , L Wang , ... , J Liu
Nature Biomedical Engineering2024
1 64
An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis.
KM Au , JE Wilson , JP Ting , AZ Wang
Nature Biomedical Engineering2023
1 78
KS Gordon , T Kyung , CR Perez , ... , ME Birnbaum
Nature Biomedical Engineering2022 - VOLUME 6, ISSUE 7 pp 855-866.
22 56
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
Soft and elastic hydrogel-based microelectronics for localized low-voltage neuromodulation.
Y Liu , J Liu , S Chen , ... , Z Bao
Nature Biomedical Engineering2019 - VOLUME 3, ISSUE 1 pp 58-68.
183 64
A Mansurov , P Hosseinchi , K Chang , ... , JA Hubbell
Nature Biomedical Engineering2022 - VOLUME 6, ISSUE 7 pp 819-829.
25 54
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens.
CL Yankaskas , KN Thompson , CD Paul , ... , K Konstantopoulos
Nature Biomedical Engineering2019 - VOLUME 3, ISSUE 6 pp 452-465.
61 59
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)
Enhanced tendon healing by a tough hydrogel with an adhesive side and high drug-loading capacity.
BR Freedman , A Kuttler , N Beckmann , ... , DJ Mooney
Nature Biomedical Engineering2022 - VOLUME 6, ISSUE 10 pp 1167-1179.
53 92
![Free / Open Access to Full Text](/assets/img/misc/oa3.png)